Last reviewed · How we verify
post operative analgesics
Post operative analgesics, developed by Ain Shams University, are currently marketed but lack detailed revenue figures and primary indication data. The key composition patent is set to expire in 2028, providing a clear timeline for potential generic competition. The absence of key trial results and identified competitors poses a significant risk to assessing the drug's market performance and competitive landscape.
At a glance
| Generic name | post operative analgesics |
|---|---|
| Also known as | pain control drug |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery (NA)
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision (NA)
- Bilateral Cervical Plexus Block for Postoperative Pain After Thyroidectomy (NA)
- HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids (NA)
- Compared Reversed US-Guided Dorsal Penile Nerve Block (RUSDPNB) With DPNB in Circumcisions for Pediatric Patients (NA)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- Analgesic Effects of Intrathecal Morphine and Transversalis Plane Block After Cesarean Delivery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- post operative analgesics CI brief — competitive landscape report
- post operative analgesics updates RSS · CI watch RSS
- Ain Shams University portfolio CI